Biomedical Catalyst Fund
Europe, Wiltshire, United Kingdom, Swindon'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.
Investor Profile
Biomedical Catalyst Fund has backed more than 16 startups, with 1 new investments in the last 12 months alone. The firm has led 10 rounds, about 63% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Grant (94%)
- Seed (6%)
Country Focus
- United Kingdom (94%)
- United States (6%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Pharmaceutical
- Life Science
- Therapeutics
- Oncology
- Biopharma
- Wellness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
